期刊文献+

冠心病危险因素促使人外周血单核细胞高表达尿激酶型纤溶酶原激活物受体的研究 被引量:6

Risk factors for coronary artery disease stimulate urokinase receptor expression on monocytes
原文传递
导出
摘要 目的分析冠心病危险因素对人外周血单核细胞上尿激酶型纤溶酶原激活物受体(uPAR)表达的影响。方法入选2005年8月至2006年3月门诊或住院的单纯高血压患者16例,单纯脂质异常患者24例,高血压合并肥胖患者18例,脂质异常合并肥胖患者18例,脂质异常高血压合并肥胖患者30例以及健康志愿者17例。每例抽取静脉血,用异硫氰酸荧光素标记的小鼠抗人CD14单克隆抗体(CD14-FITC)和藻红蛋白标记的小鼠抗人 uPAR(CD87)单克隆抗体(CD87-PE)染色;以小鼠抗人 IgG2a,k 替代 CD87-PE 作同型对照。流式细胞仪检测外周血 uPAR 阳性的单核细胞比例及单核细胞上 uPAR 的平均荧光强度(MFI)指数。结果单纯高血压患者外周血中 uPAR 阳性的单核细胞比例为(4.9±12.5)%,较之对照组的(7.7±10.3)%,差异无统计学意义;单纯脂质异常患者该比例升至(23.7±22.5)%,较前两组分别增加3.9倍和2.1倍,P<0.05。当合并肥胖时,表达uPAR 的单核细胞比例进一步升高,高血压肥胖组、脂质异常肥胖组、脂质异常高血压肥胖组分别为(32.9±30.8)%,(37.4±31.4)%和(23.8±20.5)%,与高血压组和对照组比较,均有统计学意义(均 P<0.01);校正各组年龄、体重和高敏 C 反应蛋白后,上述差异仍然存在。脂质异常组和高血压肥胖组单核细胞上 uPAR 的 MFI 指数分别为1.91±1.97和2.33±2.52,均高于对照组的0.78±0.86,P<0.05。脂质异常组 uPAR 的表达与空腹血糖水平存在直线相关关系(r=0.72,P=0.04)。结论冠心病危险因素可以显著刺激外周血单核细胞表面 uPAR 的表达,血脂异常或肥胖是引起uPAR 高表达的重要因素。 Objective To evaluate the effect of risk factors for coronary artery disease (CAD) on urokinase receptor(uPAR) expression on monocytes. Methods A total of 106 patients were enrolled and divided into five risk-factor groups: sixteen with hypertension, twenty-four with dyslipidemia, eighteen with hypertension + obesity, eighteen with dyslipidemia + obesity and thirty with hypertension + dyslipidemia + obesity. Seventeen healthy volunteers were recruited as control group. Monocyte expression of uPAR and mean fluorescence intensity index (MFI Index) of uPAR were measured by flow cytometer (FACSCalibur). Results No difference in moncocyte u-PAR expression was detected between hypertension and control group [ (4. 9±12. 5)% vs. (7.7 ±10. 3)%, P=0.74]. However, the uPAR expression was raised to (23.7 ± 22. 5 ) % in hyperlipidemia group, a 3. 9- and a 2. 1-fold increase compared with those in hypertension ( P 〈 0. 01 ) and control group ( P 〈 0. 05 ), respectively. When combined with obesity, u-PAR expression was elevated further to (32.9 ± 30. 8 ) % in hypertension + obesity group, ( 37.4 ± 31.4 ) % in dyslipidemia + obesity group and (23.8 ± 20. 5) % in hypertemion + dyslipidemia + obesity group, all having statistical significance compared with control group or hypertension group ( P 〈 0. 01 ). The results were the same when corrected by age, BMI and hs-CRP, uPAR MFI Index was increased from 0. 78 ± 0. 86 in control group to 1.91 ± 1.97 and 3.33 ± 2. 52 in dyslipidemia group and hypertemion + obesity group, respectively, P 〈 0. 05. Linear regression analysis revealed a significant correlation between uPAR expression and FBG concentration in dyslipidemia group, r = 0. 72, P = 0. 04. Conclusions uPAR expression was elevated on monocytes in patients with risk factors for CAD. Dyslipidemia and obesity may contribute to the increase of uPAR expression.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2007年第2期159-163,共5页 Chinese Journal of Cardiology
关键词 冠状动脉硬化 危险因素 单核细胞 尿纤溶酶原激活物 Coronary arteriosclerosis Risk factors Monocytes Urinary plasminogen activator
  • 相关文献

参考文献14

  • 1Saksela O,Rifkin DB.Cell-associated plasminogen activation:regulation and physiological functions.Annu Rev Cell Biol,1988,4:93-126.
  • 2Noda-Heiny H,Daugherty A,Sobel BE.Augmented urokinase receptor expression in atheroma.Arterioscler Thromb Vasc Biol,1995,15(1):37-43.
  • 3Tan X,Egami H,Nozawa F,et al.Analysis of the invasionmetastasis mechanism in pancreatic cancer:involvement of plasmin (ogen) cascade proteins in the invasion of pancreatic cancer cells.Int J Oncol,2006,28(2):369-374.
  • 4Kotzsch M,Farthmann J,Meye A,et al.Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer.Eur J Cancer,2005,41 (17):2760-2768.
  • 5Lakka SS,Rajagopal R,Rajan MK,et al.Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.Clin Cancer Res,2001,7 (4):1087-1093.
  • 6Pulukuri SM,Gondi CS,Lakka SS,et al.RNA interferencedirected knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion,survival,and tumorigenicity in vivo.J Biol Chem,2005,280(43):36529-36540.
  • 7Bauer TW,Liu W,Fan F,et al.Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met-and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.Cancer Res,2005,65(17):7775-7781.
  • 8Lupu F,Heim DA,Bachmann F,et al.Plasminogen Activator Expression in Human Atherosclerotic Lesions.Arterioscler Thromb Vasc Biol,1995,15(9):1444-1455.
  • 9Salame MY,Samani NJ,Masood I,et al.Expression of the plasminogen activator system in the human vascular wall.Atherosclerosis,2000,152(1):19-28.
  • 10Steins MB,Padro T,Schwaenen C,et al.Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall different types of atherosclerotic lesions.Blood Coagul Fibrinolysis,2004,15 (5):383-391.

同被引文献77

引证文献6

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部